Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
World J Gastroenterol. 2017 Sep 28;23(36):6726-6732. doi: 10.3748/wjg.v23.i36.6726.
To introduce an innovative intracorporeal anastomosis technique named overlapped delta-shaped anastomosis (ODA) for colon cancer cases undergoing totally laparoscopic colectomy (TLC) and to assess its feasibility and safety.
From January 2016 to March 2017, a total of 20 consecutive patients with colon cancer accepted TLC and the ODA technique at our medical center. Patient demographics, operative outcomes, perioperative complications, and pathological results were collected and analyzed.
We successfully completed TLC and the ODA procedure in all 20 cases, including 6 (30%) males and 14 (70%) females. In total, 11 (55%), 2 (10%), and 7 (35%) cases accepted right hemicolectomy, transverse hemicolectomy, and left hemicolectomy, respectively. None of the surgeries were converted to an open operation. Mean operative time was 178.5 min, and mean estimated blood loss was 58.5 mL. Mean time to first flatus was 2.5 d, and mean postoperative hospitalization duration was 6.8 d. No severe complications occurred, such as anastomotic leakage, snastomotic stenosis, anastomotic bleeding, and wound infection, except for one case who suffered from an abdominal infection and another case who suffered from gastric paralysis syndrome. Tumor recurrence was not observed in any patient during the follow-up period.
The ODA technique for colon cancer cases undergoing TLC appears to be safe and feasible, although our current results need to be verified in further studies.
介绍一种用于腹腔镜结肠癌根治术（TLC）的创新腔内吻合技术——重叠三角形吻合术（ODA），并评估其可行性和安全性。
自 2016 年 1 月至 2017 年 3 月，我院共对 20 例结肠癌患者行 TLC 和 ODA 手术。收集并分析患者的人口统计学资料、手术结果、围手术期并发症和病理结果。
我们成功完成了 20 例 TLC 和 ODA 手术，包括 6 例（30%）男性和 14 例（70%）女性。总共进行了 11 例（55%）右半结肠切除术、2 例（10%）横结肠切除术和 7 例（35%）左半结肠切除术。所有手术均未转为开腹手术。平均手术时间为 178.5 分钟，平均估计出血量为 58.5 毫升。首次排气时间平均为 2.5 天，术后平均住院时间为 6.8 天。除 1 例发生腹部感染和 1 例发生胃瘫综合征外，无吻合口漏、吻合口狭窄、吻合口出血和伤口感染等严重并发症发生。随访期间，无患者出现肿瘤复发。
对于行 TLC 的结肠癌患者，ODA 技术似乎是安全可行的，但我们目前的结果需要进一步研究证实。
